ANTISENSE MODULATION OF CASEIN KINASE 2-ALPHA EXPRESSION

Details for Australian Patent Application No. 2002251850 (hide)

Owner ISIS PHARMACEUTICALS, INC.

Inventors MCKAY, Robert; FREIER, Susan, M.; WYATT, Jacqueline, R.

Pub. Number AU-A-2002251850

PCT Pub. Number WO2002/062818

Priority 09/780,172 08.02.01 US

Filing date 31 January 2002

Wipo publication date 19 August 2002

International Classifications

C07H 021/04 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12N 015/00 Mutation or genetic engineering

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002251850

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002251851-DIGITAL MODULATION DEVICE IN A SYSTEM AND METHOD OF USING THE SAME

2002251849-NETWORK TRAFFIC REGULATION INCLUDING CONSISTENCY BASED DETECTION AND FILTERING OF PACKETS WITH SPOOF SOURCE ADDRESSES